Trial
NCT03380936
Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
Veloxis Pharmaceuticals
Condition
Kidney Transplant Rejection
Intervention
Tacrolimus Extended Release Oral Tablet [Envarsus]
Why stopped
Slower than expected recruitment rate
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-27